{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:50:52Z","timestamp":1790887852194,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010133","name":"Aarne Koskelon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.eclinm.2024.103013","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:49:40Z","timestamp":1734518980000},"page":"103013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trials"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1489-4768","authenticated-orcid":false,"given":"Sabri","family":"Soussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuukka","family":"Tarvasm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Kimmoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Ahmadiankalati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feriel","family":"Azibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia C.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Gayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6366-2859","authenticated-orcid":false,"given":"Jacob C.","family":"Jentzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Harjola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hibbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lassus","family":"Johan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"P\u00f6ss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malha","family":"Sadoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Raynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katell","family":"Peoc'h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.eclinm.2024.103013_bib1","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S2213-2600(21)00172-7","article-title":"Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 critical care clinical trialists workshop","volume":"9","author":"Arrigo","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103013_bib2","first-page":"371","article-title":"Cardiogenic shock: a major challenge for the clinical trialist","volume":"29","author":"Sarma","year":"2023","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.eclinm.2024.103013_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2020.10.054","article-title":"Shock in the cardiac intensive care unit: changes in epidemiology and prognosis over time","volume":"232","author":"Jentzer","year":"2021","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.eclinm.2024.103013_bib4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.healun.2018.07.009","article-title":"Advancing from a \u201chemodynamic model\u201d to a \u201cmechanistic disease-modifying model\u201d of cardiogenic shock","volume":"37","author":"Lawler","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.eclinm.2024.103013_bib5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1164\/rccm.201411-2125CP","article-title":"Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care","volume":"192","author":"Iwashyna","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103013_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2022.100120","article-title":"Advances in the staging and phenotyping of cardiogenic shock: part 1 of 2","volume":"1","author":"Jentzer","year":"2022","journal-title":"JACC Adv"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103013_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2022.100126","article-title":"Machine learning approaches for phenotyping in cardiogenic shock and critical illness: part 2 of 2","volume":"1","author":"Jentzer","year":"2022","journal-title":"JACC Adv"},{"issue":"20","key":"10.1016\/j.eclinm.2024.103013_bib8","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103013_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13054-022-03972-8","article-title":"Identifying clinical subtypes in sepsis-survivors with different one-year outcomes: a secondary latent class analysis of the FROG-ICU cohort","volume":"26","author":"Soussi","year":"2022","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.eclinm.2024.103013_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.eclinm.2024.103013_bib11","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/ejhf.2346","article-title":"Circulating heart failure biomarkers beyond natriuretic peptides: review from the biomarker study group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)","volume":"23","author":"Meijers","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.eclinm.2024.103013_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103013_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13054-017-1922-8","article-title":"Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study","volume":"22","author":"Gayat","year":"2018","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103013_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/ALN.0000000000003600","article-title":"Evaluation of biomarkers in critical care and perioperative medicine: a clinician's overview of traditional statistical methods and machine learning algorithms","volume":"134","author":"Soussi","year":"2021","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.eclinm.2024.103013_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.103013_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.eclinm.2024.103013_bib17","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.eclinm.2024.103013_bib18","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int J Surg"},{"issue":"9","key":"10.1016\/j.eclinm.2024.103013_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"Naidu","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.eclinm.2024.103013_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12871-015-0129-2","article-title":"Post-ICU discharge and outcome: rationale and methods of the the French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study","volume":"15","author":"Mebazaa","year":"2015","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.eclinm.2024.103013_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2020.08.069","article-title":"Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - insights from the CardShock study","volume":"322","author":"Kataja","year":"2021","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103013_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/CCM.0000000000004044","article-title":"Bioactive adrenomedullin, organ support therapies, and survival in the critically ill: results from the French and European outcome registry in ICU study","volume":"48","author":"Lemasle","year":"2020","journal-title":"Crit Care Med"},{"issue":"24","key":"10.1016\/j.eclinm.2024.103013_bib23","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/eurheartj\/ehab110","article-title":"The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction","volume":"42","author":"Ceglarek","year":"2021","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.eclinm.2024.103013_bib24","article-title":"Phenotyping cardiogenic shock","volume":"10","author":"Zweck","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.eclinm.2024.103013_bib25","first-page":"261","article-title":"Circulating biomarkers to assess cardiovascular function in critically ill","volume":"27","author":"van Lier","year":"2021","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103013_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s13054-018-2279-3","article-title":"Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysis","volume":"22","author":"Zhang","year":"2018","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103013_bib27","first-page":"392","article-title":"An outlook on biomarkers in cardiogenic shock","volume":"26","author":"Iborra-Egea","year":"2020","journal-title":"Curr Opin Crit Care"},{"issue":"6","key":"10.1016\/j.eclinm.2024.103013_bib28","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ejhf.2158","article-title":"Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure","volume":"23","author":"Boorsma","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.eclinm.2024.103013_bib29","series-title":"Technical guide for latent GOLD 5.1: basic, advanced, and syntax","author":"Vermunt","year":"2016"},{"issue":"2","key":"10.1016\/j.eclinm.2024.103013_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S2215-0366(18)30464-4","article-title":"Insomnia disorder subtypes derived from life history and traits of affect and personality","volume":"6","author":"Blanken","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.eclinm.2024.103013_bib31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103013_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/sim.6370","article-title":"Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach","volume":"34","author":"Kang","year":"2015","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.eclinm.2024.103013_bib33","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00134-022-06869-w","article-title":"Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial","volume":"48","author":"Fish","year":"2022","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.eclinm.2024.103013_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","article-title":"Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials","volume":"11","author":"Sinha","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.eclinm.2024.103013_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/thorax-2023-220130","article-title":"Identification of molecular subphenotypes in two cohorts of paediatric ARDS","volume":"79","author":"Yehya","year":"2024","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.eclinm.2024.103013_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jclinepi.2003.08.009","article-title":"Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test","volume":"57","author":"Brookes","year":"2004","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"10","key":"10.1016\/j.eclinm.2024.103013_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jchf.2023.05.007","article-title":"Clinical course of patients in cardiogenic shock stratified by phenotype","volume":"11","author":"Zweck","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.eclinm.2024.103013_bib38","first-page":"1006","article-title":"Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population","volume":"99","author":"Jentzer","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.eclinm.2024.103013_bib39","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2024.103013_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2213-2600(21)00439-2","article-title":"Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial","volume":"10","author":"Karakas","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.eclinm.2024.103013_bib41","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jchf.2023.06.024","article-title":"Precision medicine in cardiogenic shock: we are almost there!","volume":"11","author":"Mebazaa","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.eclinm.2024.103013_bib42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13054-023-04752-8","article-title":"Extending the \u201chost response\u201d paradigm from sepsis to cardiogenic shock: evidence, limitations and opportunities","volume":"27","author":"Buckel","year":"2023","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.eclinm.2024.103013_bib43","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","article-title":"Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial","volume":"47","author":"Laterre","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.eclinm.2024.103013_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1058235","article-title":"Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial","volume":"9","author":"van Lier","year":"2022","journal-title":"Front Med"},{"issue":"11","key":"10.1016\/j.eclinm.2024.103013_bib45","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00134-024-07618-x","article-title":"Management of cardiogenic shock: state-of-the-art","volume":"50","author":"Jung","year":"2024","journal-title":"Intensive Care Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024005923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024005923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:06:29Z","timestamp":1762632389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024005923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"alternative-id":["S2589537024005923"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.103013","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.103013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103013"}}